Check-Cap Ltd. (NASDAQ:CHEK) Sees Large Decrease in Short Interest

Check-Cap Ltd. (NASDAQ:CHEK) was the recipient of a large decrease in short interest during the month of April. As of April 15th, there was short interest totalling 131,100 shares, a decrease of 78.2% from the March 31st total of 600,000 shares. Based on an average trading volume of 251,300 shares, the short-interest ratio is currently 0.5 days. Currently, 3.0% of the shares of the stock are sold short.

Analyst Upgrades and Downgrades

Separately, StockNews.com started coverage on shares of Check-Cap in a research note on Tuesday. They issued a “sell” rating on the stock.

Check-Cap Trading Up 0.7 %

Shares of NASDAQ CHEK traded up $0.02 during midday trading on Friday, reaching $2.29. 22,716 shares of the stock were exchanged, compared to its average volume of 206,415. The company has a market capitalization of $13.37 million, a P/E ratio of -0.76 and a beta of 0.28. Check-Cap has a 52-week low of $1.27 and a 52-week high of $4.63. The stock has a 50 day moving average price of $2.26 and a 200-day moving average price of $2.56.

About Check-Cap

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation.